Results 101 to 110 of about 7,598 (289)

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher   +12 more
wiley   +1 more source

Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECA [PDF]

open access: yes, 2003
Guinea pig isolated working hearts were exposed to 30-min ischaemia by reducing coronary flow to 10%, followed by reperfusion. Aortic output fell to 4.5±4.5% of the pre-ischaemic value at reperfusion, recovering to 48.2±14.6% at 20-min post-reperfusion ...
Broadley, K.J.   +4 more
core   +1 more source

Imaging Techniques for the Assessment of Myocardial Perfusion

open access: yesJournal of Interdisciplinary Medicine, 2016
One of the most significant causes of heart failure is coronary heart disease and subsequent left ventricular dysfunction. The prognosis and perioperative mortality are influenced by left ventricular function, which is also an important predictor marker ...
Jáni Laura   +6 more
doaj   +1 more source

A guide to neuromodulation in drug‐resistant epilepsy

open access: yesEpileptic Disorders, EarlyView.
Abstract Neuromodulation is approved for the treatment of drug‐resistant epilepsy. It has been increasingly utilized over the past two decades with the approval of deep brain stimulation (DBS) and responsive neurostimulation (RNS) in addition to vagus nerve stimulation (VNS)—particularly in patients who are not deemed to be good resective surgical ...
Prachi Parikh   +10 more
wiley   +1 more source

Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway [PDF]

open access: yes, 1999
Previous studies have shown that administration of nitric oxide (NO) donors induces a delayed cardioprotective effect indistinguishable from the late phase of ischemic preconditioning (PC). However, the ability of clinically relevant NO donors to elicit
Roberto Bolli   +7 more
core   +1 more source

Comparative Effects of Azelnidipine and Amlodipine on Myocardial Function and Mortality After Ischemia/Reperfusion in Dogs

open access: yesJournal of Pharmacological Sciences, 2011
.: Effects of azelnidipine were examined and compared with those of amlodipine on stunned myocardium in dogs. The left anterior descending (LAD) coronary artery was ligated for 20 min and subsequently released for 60 min.
Seiichiro Kano   +3 more
doaj   +1 more source

Phytochemicals and Health Benefits of American Ginseng (Panax quinquefolius L.): Current Knowledge and Future Perspectives

open access: yesFood Safety and Health, EarlyView.
This review summarizes the chemical constituents and functional characteristics of American ginseng, aiming to provide references for its development and application. ABSTRACT American ginseng, a perennial herbaceous plant, is recognized for its significant medicinal properties and has attracted considerable attention due to its diverse phytochemical ...
Wei Geng   +5 more
wiley   +1 more source

Activation of adenosine receptors before ischemia enhances tolerance against myocardial stunning in the rabbit heart [PDF]

open access: yes, 1996
Objectives.This study examined whether stimulation of adenosine receptors before ischemia enhances myocardial resistance to stunning in vivo.Background.We previously demonstrated the attenuation of myocardial stunning by ischemic preconditioning through ...
Osamu Iimura   +7 more
core   +1 more source

Myocardial Viability: What We Knew and What Is New

open access: yesCardiology Research and Practice, 2012
Some patients with chronic ischemic left ventricular dysfunction have shown significant improvements of contractility with favorable long-term prognosis after revascularization.
Adel Shabana, Ayman El-Menyar
doaj   +1 more source

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results

open access: yesКардиоваскулярная терапия и профилактика, 2005
Metabolic cardioprotection is an important part of treating patients with coronary heart disease (CHD). The most widely used drug in this group is trimetazidine.
L. V. Kremneva   +2 more
doaj  

Home - About - Disclaimer - Privacy